CFDE Data Portal | Search FTOP1

	Label	Description
	FTOP1 associations Collection (Entity type)	Associations for FTOP1_associations
	FTOP1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	FTOP1 Gene (Entity type)	ENSG00000226491 - FTO pseudogene 1
	GSE222758 clofazimine U2OS 0 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE176008 pyridoxine 7 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE183741 GSE183806 POU2F2 POU2AF1 knockdown UtE-iPS-1 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE179332 STAT3 inhibition Reh 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	TAS2R14 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GSE175770 adenosine 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE182157 AS3MT knockout SH-SY5Y 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

FTOP1 associations

Associations for FTOP1_associations

FTOP1 associations.tsv

A file from IDG as part of the Harmonizome project

FTOP1

ENSG00000226491 - FTO pseudogene 1

GSE222758 clofazimine U2OS 0 v 4 human up

A Gene Set from LINCS

GSE176008 pyridoxine 7 v 3 human dn

A Gene Set from LINCS

GSE183741 GSE183806 POU2F2 POU2AF1 knockdown UtE-iPS-1 2 v 4 human up

A Gene Set from LINCS

GSE179332 STAT3 inhibition Reh 0 v 1 human up

A Gene Set from LINCS

TAS2R14 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

GSE175770 adenosine 0 v 1 human dn

A Gene Set from LINCS

GSE182157 AS3MT knockout SH-SY5Y 1 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.